Latest news with #Q1earnings
Yahoo
2 days ago
- Business
- Yahoo
Specialized Technology Stocks Q1 Highlights: OSI Systems (NASDAQ:OSIS)
As the Q1 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the specialized technology industry, including OSI Systems (NASDAQ:OSIS) and its peers. Companies in this sector, especially if they invest wisely, could see demand tailwinds as the world moves towards more IoT (Internet of Things), automation, and analytics. Enterprises across most industries will balk at taking these journeys solo and will enlist companies with expertise and scale in these areas. However, headwinds could include rising competition from larger technology firms, as digitization lowers barriers to entry in the space. Additionally, companies in the space will likely face evolving regulatory scrutiny over data privacy, particularly for surveillance and security technologies. This could make companies have to continually pivot and invest. The 8 specialized technology stocks we track reported a strong Q1. As a group, revenues beat analysts' consensus estimates by 1.3% while next quarter's revenue guidance was in line. Luckily, specialized technology stocks have performed well with share prices up 28.7% on average since the latest earnings results. OSI Systems (NASDAQ:OSIS) With security scanners deployed at airports and borders worldwide and patient monitors used in hospitals across the globe, OSI Systems (NASDAQ:OSIS) designs and manufactures specialized electronic systems for security screening, patient monitoring, and optoelectronic applications. OSI Systems reported revenues of $444.4 million, up 9.6% year on year. This print exceeded analysts' expectations by 1.4%. Overall, it was a satisfactory quarter for the company with a narrow beat of analysts' EPS estimates. Ajay Mehra, OSI Systems' President and Chief Executive Officer, stated, 'We are pleased to report a record-breaking third quarter for revenues, non-GAAP earnings and operating cash flow, led by excellent performance in the Security division and growth in the Optoelectronics and Manufacturing division. With record backlog and high visibility into our opportunity pipeline, we anticipate a strong finish to fiscal 2025.' Interestingly, the stock is up 10.4% since reporting and currently trades at $226.08. Is now the time to buy OSI Systems? Access our full analysis of the earnings results here, it's free. Best Q1: Arlo Technologies (NYSE:ARLO) Originally spun off from networking equipment maker Netgear in 2018, Arlo Technologies (NYSE:ARLO) provides cloud-based smart security devices and subscription services that help consumers and businesses monitor and protect their homes, properties, and loved ones. Arlo Technologies reported revenues of $119.1 million, down 4.1% year on year, outperforming analysts' expectations by 0.6%. The business had an exceptional quarter with a solid beat of analysts' EPS estimates. The market seems happy with the results as the stock is up 51.9% since reporting. It currently trades at $16.19. Is now the time to buy Arlo Technologies? Access our full analysis of the earnings results here, it's free. Zebra (NASDAQ:ZBRA) Taking its name from the black and white stripes of barcodes, Zebra Technologies (NASDAQ:ZBRA) provides barcode scanners, mobile computers, RFID systems, and other data capture technologies that help businesses track assets and optimize operations. Zebra reported revenues of $1.31 billion, up 11.3% year on year, exceeding analysts' expectations by 1.4%. Still, it was a slower quarter as it posted a significant miss of analysts' EPS guidance for next quarter estimates and revenue guidance for next quarter slightly missing analysts' expectations. Interestingly, the stock is up 37.6% since the results and currently trades at $335.10. Read our full analysis of Zebra's results here. PAR Technology (NYSE:PAR) Originally founded in 1968 as a defense contractor for the U.S. government, PAR Technology (NYSE:PAR) provides cloud-based software, payment processing, and hardware solutions that help restaurants manage everything from point-of-sale to customer loyalty programs. PAR Technology reported revenues of $103.9 million, up 48.2% year on year. This print lagged analysts' expectations by 1.4%. Zooming out, it was a mixed quarter as it also recorded an impressive beat of analysts' EPS estimates but a miss of analysts' ARR estimates. PAR Technology scored the fastest revenue growth but had the weakest performance against analyst estimates among its peers. The stock is up 9.4% since reporting and currently trades at $68.26. Read our full, actionable report on PAR Technology here, it's free. Cognex (NASDAQ:CGNX) Founded in 1981 when computer vision was in its infancy, Cognex (NASDAQ:CGNX) develops machine vision systems and software that help manufacturers and logistics companies automate quality inspection and tracking of products. Cognex reported revenues of $216 million, up 2.5% year on year. This number surpassed analysts' expectations by 1.9%. Overall, it was a strong quarter as it also recorded a solid beat of analysts' EPS estimates. The stock is up 24.9% since reporting and currently trades at $34.06. Read our full, actionable report on Cognex here, it's free. Market Update In response to the Fed's rate hikes in 2022 and 2023, inflation has been gradually trending down from its post-pandemic peak, trending closer to the Fed's 2% target. Despite higher borrowing costs, the economy has avoided flashing recessionary signals. This is the much-desired soft landing that many investors hoped for. The recent rate cuts (0.5% in September and 0.25% in November 2024) have bolstered the stock market, making 2024 a strong year for equities. Donald Trump's presidential win in November sparked additional market gains, sending indices to record highs in the days following his victory. However, debates continue over possible tariffs and corporate tax adjustments, raising questions about economic stability in 2025. Want to invest in winners with rock-solid fundamentals? Check out our Hidden Gem Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
Q1 Earnings Outperformers: Vital Farms (NASDAQ:VITL) And The Rest Of The Perishable Food Stocks
As the Q1 earnings season wraps, let's dig into this quarter's best and worst performers in the perishable food industry, including Vital Farms (NASDAQ:VITL) and its peers. The perishable food industry is diverse, encompassing large-scale producers and distributors to specialty and artisanal brands. These companies sell produce, dairy products, meats, and baked goods and have become integral to serving modern American consumers who prioritize freshness, quality, and nutritional value. Investing in perishable food stocks presents both opportunities and challenges. While the perishable nature of products can introduce risks related to supply chain management and shelf life, it also creates a constant demand driven by the necessity for fresh food. Companies that can efficiently manage inventory, distribution, and quality control are well-positioned to thrive in this competitive market. Navigating the perishable food industry requires adherence to strict food safety standards, regulations, and labeling requirements. The 11 perishable food stocks we track reported a slower Q1. As a group, revenues beat analysts' consensus estimates by 3.4%. In light of this news, share prices of the companies have held steady as they are up 1.5% on average since the latest earnings results. Vital Farms (NASDAQ:VITL) With an emphasis on ethically produced products, Vital Farms (NASDAQ:VITL) specializes in pasture-raised eggs and butter. Vital Farms reported revenues of $162.2 million, up 9.6% year on year. This print was in line with analysts' expectations, and overall, it was a very strong quarter for the company with an impressive beat of analysts' EPS estimates and a solid beat of analysts' EBITDA estimates. 'We delivered first quarter results that were in-line with our overall expectations and made good progress on our key 2025 strategic initiatives, said Russell Diez-Canseco, Vital Farms' President and Chief Executive Officer. 'We demonstrated solid execution, ongoing business momentum, and our continued focus on bringing ethical food to the table. Vital Farms scored the highest full-year guidance raise of the whole group. Unsurprisingly, the stock is up 2.8% since reporting and currently trades at $37. We think Vital Farms is a good business, but is it a buy today? Read our full report here, it's free. Best Q1: Mission Produce (NASDAQ:AVO) Founded in 1983 in California, Mission Produce (NASDAQ:AVO) grows, packages, and distributes avocados. Mission Produce reported revenues of $380.3 million, up 27.8% year on year, outperforming analysts' expectations by 28.4%. The business had a stunning quarter with a solid beat of analysts' EPS estimates and an impressive beat of analysts' EBITDA estimates. Mission Produce scored the biggest analyst estimates beat among its peers. The market seems happy with the results as the stock is up 14.3% since reporting. It currently trades at $12.05. Is now the time to buy Mission Produce? Access our full analysis of the earnings results here, it's free. Weakest Q1: Beyond Meat (NASDAQ:BYND) A pioneer at the forefront of the plant-based protein revolution, Beyond Meat (NASDAQ:BYND) is a food company specializing in alternatives to traditional meat products. Beyond Meat reported revenues of $68.73 million, down 9.1% year on year, falling short of analysts' expectations by 8.3%. It was a disappointing quarter as it posted a significant miss of analysts' adjusted operating income estimates and a significant miss of analysts' EBITDA estimates. Beyond Meat delivered the weakest performance against analyst estimates and slowest revenue growth in the group. Interestingly, the stock is up 43.1% since the results and currently trades at $3.65. Read our full analysis of Beyond Meat's results here. Pilgrim's Pride (NASDAQ:PPC) Offering everything from pre-marinated to frozen chicken, Pilgrim's Pride (NASDAQ:PPC) produces, processes, and distributes chicken products to retailers and food service customers. Pilgrim's Pride reported revenues of $4.46 billion, up 2.3% year on year. This result came in 1.6% below analysts' expectations. Overall, it was a softer quarter as it also recorded a miss of analysts' EBITDA estimates and a miss of analysts' gross margin estimates. The stock is down 12.2% since reporting and currently trades at $47.90. Read our full, actionable report on Pilgrim's Pride here, it's free. Cal-Maine (NASDAQ:CALM) Known for brands such as Egg-Land's Best and Land O' Lakes, Cal-Maine (NASDAQ:CALM) produces, packages, and distributes eggs. Cal-Maine reported revenues of $1.10 billion, up 72.2% year on year. This print topped analysts' expectations by 21.3%. It was a very strong quarter as it also logged a solid beat of analysts' EBITDA estimates and a decent beat of analysts' adjusted operating income estimates. Cal-Maine delivered the fastest revenue growth among its peers. The stock is flat since reporting and currently trades at $105.20. Read our full, actionable report on Cal-Maine here, it's free. Market Update Thanks to the Fed's rate hikes in 2022 and 2023, inflation has been on a steady path downward, easing back toward that 2% sweet spot. Fortunately (miraculously to some), all this tightening didn't send the economy tumbling into a recession, so here we are, cautiously celebrating a soft landing. The cherry on top? Recent rate cuts (half a point in September 2024, a quarter in November) have propped up markets, especially after Trump's November win lit a fire under major indices and sent them to all-time highs. However, there's still plenty to ponder — tariffs, corporate tax cuts, and what 2025 might hold for the economy. Want to invest in winners with rock-solid fundamentals? Check out our 9 Best Market-Beating Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio
Yahoo
09-07-2025
- Business
- Yahoo
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Merck (NYSE:MRK)
As the Q1 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the branded pharmaceuticals industry, including Merck (NYSE:MRK) and its peers. Looking ahead, the branded pharmaceutical industry is positioned for tailwinds from advancements in precision medicine, increasing adoption of AI to enhance drug development efficiency, and growing global demand for treatments addressing chronic and rare diseases. However, headwinds include heightened regulatory scrutiny, pricing pressures from governments and insurers, and the looming patent cliffs for key blockbuster drugs. Patent cliffs bring about competition from generics, forcing branded pharmaceutical companies back to the drawing board to find the next big thing. The 10 branded pharmaceuticals stocks we track reported a satisfactory Q1. As a group, revenues were in line with analysts' consensus estimates. In light of this news, share prices of the companies have held steady. On average, they are relatively unchanged since the latest earnings results. With roots dating back to 1891 and a portfolio that includes the blockbuster cancer immunotherapy Keytruda, Merck (NYSE:MRK) develops and sells prescription medicines, vaccines, and animal health products across oncology, infectious diseases, cardiovascular, and other therapeutic areas. Merck reported revenues of $15.53 billion, down 1.6% year on year. This print exceeded analysts' expectations by 1.6%. Overall, it was a strong quarter for the company with a solid beat of analysts' constant currency revenue estimates and a decent beat of analysts' EPS estimates. 'Our company made strong progress to start the year, with increasing contributions from our newer commercialized medicines and vaccines and continued advancement of our pipeline,' said Robert M. Davis, chairman and chief executive officer, Merck. Interestingly, the stock is up 3.6% since reporting and currently trades at $81.50. We think Merck is a good business, but is it a buy today? Read our full report here, it's free. With roots dating back to 1887 and a transformative merger in 1989 that gave the company its current name, Bristol-Myers Squibb (NYSE:BMY) discovers, develops, and markets prescription medications for serious diseases including cancer, blood disorders, immunological conditions, and cardiovascular diseases. Bristol-Myers Squibb reported revenues of $11.2 billion, down 5.6% year on year, outperforming analysts' expectations by 3.9%. The business had a very strong quarter with a solid beat of analysts' EPS estimates and full-year revenue guidance slightly topping analysts' expectations. Bristol-Myers Squibb scored the biggest analyst estimates beat among its peers. Although it had a fine quarter compared its peers, the market seems unhappy with the results as the stock is down 3% since reporting. It currently trades at $47.07. Is now the time to buy Bristol-Myers Squibb? Access our full analysis of the earnings results here, it's free. Founded in 1876 by a Civil War veteran and pharmacist frustrated with the poor quality of medicines, Eli Lilly (NYSE:LLY) discovers, develops, and manufactures pharmaceutical products for conditions including diabetes, obesity, cancer, immunological disorders, and neurological diseases. Eli Lilly reported revenues of $12.73 billion, up 45.2% year on year, exceeding analysts' expectations by 0.9%. Still, it was a slower quarter as it posted a significant miss of analysts' full-year EPS guidance estimates and a miss of analysts' EPS estimates. As expected, the stock is down 13% since the results and currently trades at $779.69. Read our full analysis of Eli Lilly's results here. Spun off from Merck in 2021 to create a company dedicated to addressing unmet needs in women's health, Organon (NYSE:OGN) is a global healthcare company focused on improving women's health through prescription therapies, medical devices, biosimilars, and established medicines. Organon reported revenues of $1.51 billion, down 6.7% year on year. This result surpassed analysts' expectations by 0.6%. Overall, it was a strong quarter as it also put up a solid beat of analysts' EPS estimates. The stock is down 22.5% since reporting and currently trades at $10. Read our full, actionable report on Organon here, it's free. With a diverse portfolio of eight FDA-approved medications targeting neurological conditions, Supernus Pharmaceuticals (NASDAQ:SUPN) develops and markets treatments for central nervous system disorders including epilepsy, ADHD, Parkinson's disease, and migraine. Supernus Pharmaceuticals reported revenues of $149.8 million, up 4.3% year on year. This print beat analysts' expectations by 1.3%. Aside from that, it was a slower quarter as it logged full-year operating income guidance missing analysts' expectations. Supernus Pharmaceuticals had the weakest full-year guidance update among its peers. The stock is down 1.1% since reporting and currently trades at $32.09. Read our full, actionable report on Supernus Pharmaceuticals here, it's free. The Fed's interest rate hikes throughout 2022 and 2023 have successfully cooled post-pandemic inflation, bringing it closer to the 2% target. Inflationary pressures have eased without tipping the economy into a recession, suggesting a soft landing. This stability, paired with recent rate cuts (0.5% in September 2024 and 0.25% in November 2024), fueled a strong year for the stock market in 2024. The markets surged further after Donald Trump's presidential victory in November, with major indices reaching record highs in the days following the election. Still, questions remain about the direction of economic policy, as potential tariffs and corporate tax changes add uncertainty for 2025. Want to invest in winners with rock-solid fundamentals? Check out our Top 6 Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
03-07-2025
- Business
- Yahoo
Q1 Rundown: Dynatrace (NYSE:DT) Vs Other Software Development Stocks
Looking back on software development stocks' Q1 earnings, we examine this quarter's best and worst performers, including Dynatrace (NYSE:DT) and its peers. As legendary VC investor Marc Andreessen says, "Software is eating the world", and it touches virtually every industry. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. The 11 software development stocks we track reported a strong Q1. As a group, revenues beat analysts' consensus estimates by 2.3% while next quarter's revenue guidance was in line. Luckily, software development stocks have performed well with share prices up 16% on average since the latest earnings results. Founded in Austria in 2005, Dynatrace (NYSE:DT) provides companies with software that allows them to monitor the performance of their full technology stack, from software applications to the infrastructure they run on. Dynatrace reported revenues of $445.2 million, up 16.9% year on year. This print exceeded analysts' expectations by 2.4%. Overall, it was a very strong quarter for the company with EPS guidance for next quarter exceeding analysts' expectations and a solid beat of analysts' EBITDA estimates. "Dynatrace delivered a strong finish to fiscal 2025. Our fourth quarter results exceeded guidance on all of our key operating metrics, fueled by broad consumption growth across the platform," said Rick McConnell, Chief Executive Officer of Dynatrace. Dynatrace scored the highest full-year guidance raise of the whole group. Unsurprisingly, the stock is up 8.5% since reporting and currently trades at $54.80. We think Dynatrace is a good business, but is it a buy today? Read our full report here, it's free. Founded in 2011, Fastly (NYSE:FSLY) provides content delivery and edge cloud computing services, enabling enterprises and developers to deliver fast, secure, and scalable digital content and experiences. Fastly reported revenues of $144.5 million, up 8.2% year on year, outperforming analysts' expectations by 4.8%. The business had an exceptional quarter with an impressive beat of analysts' EBITDA estimates. Fastly achieved the biggest analyst estimates beat among its peers. The market seems happy with the results as the stock is up 15.1% since reporting. It currently trades at $6.92. Is now the time to buy Fastly? Access our full analysis of the earnings results here, it's free. Initially started as a hardware appliances company in the late 1990s, F5 (NASDAQ:FFIV) makes software that helps large enterprises ensure their web applications are always available by distributing network traffic and protecting them from cyberattacks. F5 reported revenues of $731.1 million, up 7.3% year on year, exceeding analysts' expectations by 1.7%. Still, it was a mixed quarter as it posted EPS guidance for next quarter missing analysts' expectations. Interestingly, the stock is up 11.4% since the results and currently trades at $295.21. Read our full analysis of F5's results here. Founded in 2008 by Jeff Lawson, a former engineer at Amazon, Twilio (NYSE:TWLO) is a software as a service platform that makes it really easy for software developers to use text messaging, voice calls and other forms of communication in their apps. Twilio reported revenues of $1.17 billion, up 12% year on year. This number surpassed analysts' expectations by 2.6%. Overall, it was a strong quarter as it also recorded accelerating customer growth and a solid beat of analysts' EBITDA estimates. The company added 10,000 customers to reach a total of 335,000. The stock is up 18.8% since reporting and currently trades at $116.30. Read our full, actionable report on Twilio here, it's free. Founded by two grad students of Harvard Business School, Cloudflare (NYSE:NET) is a software-as-a-service platform that helps improve the security, reliability, and loading times of internet applications. Cloudflare reported revenues of $479.1 million, up 26.5% year on year. This print beat analysts' expectations by 2.1%. Aside from that, it was a decent quarter as it also logged an impressive beat of analysts' billings estimates. The stock is up 49.1% since reporting and currently trades at $185.64. Read our full, actionable report on Cloudflare here, it's free. Thanks to the Fed's series of rate hikes in 2022 and 2023, inflation has cooled significantly from its post-pandemic highs, drawing closer to the 2% goal. This disinflation has occurred without severely impacting economic growth, suggesting the success of a soft landing. The stock market thrived in 2024, spurred by recent rate cuts (0.5% in September and 0.25% in November), and a notable surge followed Donald Trump's presidential election win in November, propelling indices to historic highs. Nonetheless, the outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. The path forward holds both optimism and caution as new policies take shape. Want to invest in winners with rock-solid fundamentals? Check out our 9 Best Market-Beating Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Sign in to access your portfolio
Yahoo
30-06-2025
- Business
- Yahoo
Regional Banks Stocks Q1 In Review: First Financial Bankshares (NASDAQ:FFIN) Vs Peers
Looking back on regional banks stocks' Q1 earnings, we examine this quarter's best and worst performers, including First Financial Bankshares (NASDAQ:FFIN) and its peers. Regional banks, financial institutions operating within specific geographic areas, serve as intermediaries between local depositors and borrowers. They benefit from rising interest rates that improve net interest margins (the difference between loan yields and deposit costs), digital transformation reducing operational expenses, and local economic growth driving loan demand. However, these banks face headwinds from fintech competition, deposit outflows to higher-yielding alternatives, credit deterioration (increasing loan defaults) during economic slowdowns, and regulatory compliance costs. Recent concerns about regional bank stability following high-profile failures and significant commercial real estate exposure present additional challenges. The 105 regional banks stocks we track reported a mixed Q1. As a group, revenues missed analysts' consensus estimates by 1.6%. Thankfully, share prices of the companies have been resilient as they are up 7.5% on average since the latest earnings results. With roots dating back to 1890 and a network spanning over 70 locations across the Lone Star State, First Financial Bankshares (NASDAQ:FFIN) is a Texas-focused regional bank providing commercial banking, trust services, and wealth management across numerous communities throughout the state. First Financial Bankshares reported revenues of $149 million, up 12.7% year on year. This print exceeded analysts' expectations by 1.7%. Despite the top-line beat, it was still a mixed quarter for the company with a solid beat of analysts' tangible book value per share estimates but EPS in line with analysts' estimates. "Our improved results from first quarter 2024 were primarily due to an increase in net interest income related to our balance sheet growth over the previous year. Strong deposit inflows have supported loan growth as well as continued bond investments which has supported margin growth in addition to bolstering our liquidity," said F. Scott Dueser, Chairman and CEO. Interestingly, the stock is up 10.7% since reporting and currently trades at $36.14. Is now the time to buy First Financial Bankshares? Access our full analysis of the earnings results here, it's free. Founded in 1784 as one of the oldest banks in the Western Hemisphere, Butterfield Bank (NYSE:NTB) provides banking, wealth management, and trust services to individuals and businesses in select offshore financial centers including Bermuda, Cayman Islands, and the Channel Islands. Butterfield Bank reported revenues of $147.8 million, up 3.7% year on year, outperforming analysts' expectations by 4.4%. The business had a stunning quarter with a solid beat of analysts' net interest income estimates and an impressive beat of analysts' EPS estimates. The market seems happy with the results as the stock is up 5.1% since reporting. It currently trades at $44.60. Is now the time to buy Butterfield Bank? Access our full analysis of the earnings results here, it's free. Originally focused on traditional banking before pivoting to serve the transportation sector, Triumph Financial (NASDAQ:TFIN) provides specialized financial services to the trucking industry, including payments processing, factoring, banking, and data intelligence solutions. Triumph Financial reported revenues of $100.8 million, flat year on year, falling short of analysts' expectations by 3.8%. It was a disappointing quarter as it posted a significant miss of analysts' tangible book value per share and net interest income estimates. Interestingly, the stock is up 18.9% since the results and currently trades at $59.22. Read our full analysis of Triumph Financial's results here. Tracing its roots back to 1863 during the Civil War era, 1st Source Corporation (NASDAQ:SRCE) is a regional bank holding company that provides commercial, consumer, specialty finance, and wealth management services across Indiana, Michigan, and Florida. 1st Source reported revenues of $104 million, up 10.6% year on year. This number beat analysts' expectations by 3.1%. Overall, it was a very strong quarter as it also logged a solid beat of analysts' net interest income estimates and a decent beat of analysts' EPS estimates. The stock is flat since reporting and currently trades at $61.84. Read our full, actionable report on 1st Source here, it's free. With roots dating back to 1982 and a strong presence in the Mid-Atlantic region, United Bankshares (NASDAQ:UBSI) is a bank holding company that provides commercial and retail banking services through its United Bank subsidiary across multiple states. United Bankshares reported revenues of $289.6 million, up 13.7% year on year. This print surpassed analysts' expectations by 4.1%. It was a stunning quarter as it also produced an impressive beat of analysts' EPS estimates and a solid beat of analysts' net interest income estimates. The stock is down 1.6% since reporting and currently trades at $36.43. Read our full, actionable report on United Bankshares here, it's free. As a result of the Fed's rate hikes in 2022 and 2023, inflation has come down from frothy levels post-pandemic. The general rise in the price of goods and services is trending towards the Fed's 2% goal as of late, which is good news. The higher rates that fought inflation also didn't slow economic activity enough to catalyze a recession. So far, soft landing. This, combined with recent rate cuts (half a percent in September 2024 and a quarter percent in November 2024) have led to strong stock market performance in 2024. The icing on the cake for 2024 returns was Donald Trump's victory in the U.S. Presidential Election in early November, sending major indices to all-time highs in the week following the election. Still, debates around the health of the economy and the impact of potential tariffs and corporate tax cuts remain, leaving much uncertainty around 2025. Want to invest in winners with rock-solid fundamentals? Check out our Hidden Gem Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.
